Teams go the extra mile to increase uptake of injectable artesunate for severe malaria
A project team meeting was recently held in Kampala, Uganda to review the work undertaken over the last 18 months to roll-out the Improving Severe Malaria Outcomes (ISMO) project, funded by UNITAID.
The aim of this project is to improve the availability of injectable artesunate (Inj AS) for the treatment of severe malaria in six malaria-endemic countries: Cameroon, Ethiopia, Kenya, Malawi, Nigeria, and Uganda. The meeting brought together implementing partners Clinton Health Access Initiative (CHAI) and Malaria Consortium to share their best practice examples and key learnings to improve and strengthen project implementation.
At the meeting, MMV presented certificates of appreciation in recognition of the hard work of ISMO team members who have gone the extra mile to make the project a success.
The first award went to the CHAI and Malaria Consortium Nigeria teams for training. They have made an outstanding contribution by supporting the ISMO Project in 13 Nigerian states, working closely with the National Malaria Elimination Program (NMEP) to roll-out severe malaria training programmes.
Other certificates of appreciation were awarded to:
The Cameroon CHAI team - Best Practice for Advocacy
Edward Idenu, Malaria Consortium Nigeria - Best Practice for Delivery
Asif Ali, CHAI - Certificate of Appreciation for his noteworthy contribution and collaboration
Alexis Kamdjou, MMV - Certificate of Appreciation for outstanding contribution and leadership
A BIG congratulations to the award recipients!
And most importantly, many thanks to the collaborating team members in each of the ISMO countries who are helping make this project an inspirational success – helping save lives with better medicines for severe malaria.